The toxicity profile of lazertinib has been noted to include manageable side effects typical of EGFR inhibitors, such as rash and diarrhea, without the severe cardiotoxicity or interstitial lung disease often associated with this drug class. The gene discussed is EGFR; the disease is interstitial lung disease.